B. Phillips

发表

Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study

Patrick C. Fiaux, D. Tsui, F. Marass, 2022, PloS one.

Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam.

A. Mutsaers, R. Straw, B. Phillips, 2004, Australian veterinary journal.

Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).

H. Erb, N. Northrup, K. Selting, 2011, Journal of the American Veterinary Medical Association.

Optimizing the Diagnostic use of a Small Clinical Biopsy

B. Madewell, B. Phillips, S. A. Kraegel, 1999, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003).

H. Erb, T. Gieger, B. Njaa, 2006, Journal of the American Veterinary Medical Association.

Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats.

D. Thamm, D. Vail, J. Obradovich, 2002, Journal of veterinary internal medicine.

Acute reactions in dogs treated with doxorubicin: increased frequency with the use of a generic formulation.

B. Madewell, B. Phillips, E. Simonson, 1998, Journal of veterinary internal medicine.

Evaluation of the oral antimitotic agent (ABT-751) in dogs with lymphoma.

C. Khanna, A. Krivoshik, E. McKeegan, 2012, Journal of veterinary internal medicine.

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

Robert S. Benjamin, Ravi Murthy, Bert Vogelstein, 2014, Science Translational Medicine.

Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.

B. Powers, C. Khanna, D. Vail, 2009, Journal of the American Animal Hospital Association.

Apoptotic and Proliferation Indexes in Canine Lymphoma

S. Griffey, M. Winthrop, B. Madewell, 2000, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

D. Thamm, T. Fan, D. Vail, 2017, Journal of veterinary internal medicine.

ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice

Annette N Smith, B. Phillips, A. Flory, 2018, Journal of veterinary internal medicine.

Preclinical study of dolastatin-10 in dogs with spontaneous neoplasia

D. Thamm, D. Vail, G. Pettit, 2002, Cancer Chemotherapy and Pharmacology.

Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials

D. Thamm, T. Fan, D. Vail, 2020, Veterinary and comparative oncology.

Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses

D. Thamm, T. Fan, D. Vail, 2018, Veterinary and Comparative Oncology.

Evaluation of single-agent mitoxantrone as chemotherapy for relapsing canine lymphoma.

B. Madewell, M. D. Lucroy, B. Phillips, 1998, Journal of veterinary internal medicine.

Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma

D. Thamm, P. Bergman, A. Avery, 2021, Journal of veterinary internal medicine.

Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.

J. Kinet, P. Dubreuil, G. Ogilvie, 2010, American journal of veterinary research.

Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.

R. Dubielzig, C. Rodriguez, B. Madewell, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.

D. Thamm, C. London, D. Vail, 2012, Veterinary and comparative oncology.

Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study

M. Pennell, D. Thamm, C. London, 2015, PloS one.

Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs

D. Grosu, K. Kruglyak, B. Coomber, 2023, Journal of veterinary internal medicine.

A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs.

D. Thamm, M. Martano, J. Hirschberger, 2012, Journal of veterinary internal medicine.

Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors.

A. Hershey, L. Forrest, D. Vail, 2004, Journal of veterinary internal medicine.

Post-chemotherapy perforation in cats with discrete intermediate- or large-cell gastrointestinal lymphoma

J. Mahoney, B. Phillips, A. Flory, 2017, Journal of feline medicine and surgery.

Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs.

M. Lindstrom, E. Dickerson, S. Helfand, 1999, Veterinary immunology and immunopathology.